Trial Profile
The Effect of Enzastaurin on CYP2C9: Enzastaurin - S-Warfarin Drug Interaction Study in Patients With Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Enzastaurin (Primary) ; Warfarin
- Indications Lymphoma; Solid tumours
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.